Thanks to the many people involved from ED leadership, clinicians, IT, and our funders @PennInjury. @PennLDI @CAMP_Penn @PennNudgeUnit

Now that the X-waiver has been X’ed ( https://t.co/7ka8Z1ouWq) , we have a huge potential pool of buprenorphine prescribers in EDs. We have more work to do, but we hope strategies like ours can help other EDs out there trying to do this work.

These results built on already high rates of OUD treatment in EDs, mainly by increasing prescribing among low-adopters. Importantly, this intervention was implemented as part of usual care with minimal support, representing real-world clinical practice.

We also saw a 5% increase in buprenorphine rx's and a 12% increase in Narcan rx's at discharge. Put another way, for every 20 patients with OUD exposed to this new pathway, one additional patient received a bupe prescription at discharge.

Breaking it down: We found that withdrawal assessments with COWS increased substantially in patients with OUD with screening intervention implementation. This is the first step in assessing patients with OUD and potentially starting treatment.

Here, we compared three EDs that implemented universal triage screening with 2 others that did not. At a high level, we found that screening was widely adopted, feasible, and associated with significant increases in the assessment and treatment of OUD.

First, we worked with ED stakeholders to design + implement a universal triage screening with automated prompts to physicians and nurses to assess and treat OUD. More on that here:

Really excited to share our work out in Annals of EM Paper: https://t.co/BNKJirtOpR Press release:  https://t.co/Q1QJxnNBLc @kit_delgadoMD @JMPerroneMD @nicolemodonnell #rachelmcfadden #jeffmoon

First big steps toward freedom for people on methadone! SAMHSA released "The Guidance" today authorizing increased take-home bottles and a decreased focus on drug-screens for people who are doing well. Push your local OTP to change!

Our team and colleagues presenting at ASAM today on Buprenorphine Telehealth @JMPerroneMD @nicolemodonnell @m_lowenstein

So proud of @_earth2brittany for this great work!

Cool study of academic 🏥 re role of consultants in mgt of recurrent IDU-endocarditis by @jess_meisner @m_lowenstein. When cardiac surg decides alone they typically decline operation (86%). Small sample but in line w/our 2020 survey of cardiac surgeons. 1/ https://t.co/toQnUspTX8

Check out this amazing work led by @especially_APT to improve care for patients with opioid use disorder in the hospital.

New research out in @nejmcatalyst finds that the telemedicine program CareConnect helps eliminate barriers to treatment for patients with opioid use disorder (#OUD) ft. @m_lowenstein, @JMPerroneMD & @nicolemodonnell (@CAMP_penn) https://t.co/yYTyq6HoGg

Kudos to @Jas_B417 and the whole team for this amazing work https://t.co/AeXsmaMvZm

Thx @aubreyjwhelan @PhillyInquirer for coverage of our @PennMedicine safety net CareConnect warmline for substance use tx. Grateful for dedicated @CAMP_Penn team @nicolemodonnell @m_lowenstein Jasmine, Gilly @_earth2brittany

@PennMedicine @PennLDI @NCSP_Penn @CHERISHresearch @kwstark @aubreyjwhelan @kit_delgadoMD @PennDGIMProud

And thanks to the whole team @CAMP_Penn @JMPerroneMD Kathryn Gallagher Jon Pomeroy @khchaiyachati Susan McGinley Emily Cubbage @_earth2brittany @shoshiaronowitz @rachel_e_french

Also shout-out to #PMOD for embracing this project and taking amazing care of our patients.